Jacques J. M. J. M. Van Dongen

Jacques J. M. J. M. Van Dongen's AcademicInfluence.com Rankings

Medical

#2786

World Rank

#3221

Historical Rank

Hematology

#39

World Rank

#45

Historical Rank

medical Degrees

Download Badge

Medical

Jacques J. M. J. M. Van Dongen's Degrees

PhD Biomedical Sciences University of Amsterdam
Masters Biomedical Sciences University of Amsterdam
Bachelors Biomedical Sciences University of Amsterdam

Why Is Jacques J. M. J. M. Van Dongen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques J. M. J. M. Van Dongen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. (2001) (861)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes (2012) (720)
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. (1997) (716)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. (2010) (697)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols (2012) (579)
An antibody-deficiency syndrome due to mutations in the CD19 gene. (2006) (517)
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence (2005) (422)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma (2017) (419)
The MLL recombinome of acute leukemias in 2013 (2013) (408)
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. (2015) (375)
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations (2012) (375)
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. (2010) (358)
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling (2005) (357)
Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. (2011) (357)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. (2011) (356)
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells. (2001) (320)
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells (2009) (309)
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency (2011) (305)
Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. (2011) (301)
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. (2017) (292)
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. (2006) (279)
Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion (2007) (273)
New criteria for response assessment: role of minimal residual disease in multiple myeloma. (2015) (265)
E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. (2000) (264)
A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. (2008) (260)
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. (2010) (248)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. (2016) (232)
Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects. (1991) (227)
Minimal residual disease in leukaemia patients. (2001) (227)
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages (1993) (220)
Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. (2001) (217)
Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. (1991) (202)
Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. (2009) (199)
Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. (1992) (191)
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma (2016) (182)
A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. (2005) (181)
Flow cytometric analysis of the Vbeta repertoire in healthy controls. (2000) (181)
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. (2007) (176)
CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy. (2007) (176)
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. (2005) (171)
Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. (1994) (166)
Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. (2002) (159)
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. (2002) (154)
Age‐associated distribution of normal B‐cell and plasma cell subsets in peripheral blood (2018) (146)
Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype (2012) (145)
Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody (1988) (143)
Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. (1990) (143)
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes (1993) (142)
Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. (1993) (138)
Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. (1991) (137)
Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. (1997) (137)
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. (2001) (137)
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma. (2019) (133)
Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. (2006) (132)
Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. (1999) (131)
Ig Gene Rearrangement Steps Are Initiated in Early Human Precursor B Cell Subsets and Correlate with Specific Transcription Factor Expression1 (2005) (131)
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study (2019) (130)
Wnt Target Genes Identified by DNA Microarrays in Immature CD34+ Thymocytes Regulate Proliferation and Cell Adhesion1 (2004) (130)
The Same IκBα Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes (2004) (130)
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients. (2016) (128)
The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. (1991) (127)
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping (2010) (121)
B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. (2011) (119)
Overview of clinical flow cytometry data analysis: recent advances and future challenges. (2013) (118)
Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. (2006) (115)
T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. (1987) (114)
Venetoclax and obinutuzumab in chronic lymphocytic leukemia. (2017) (113)
Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease (2000) (111)
Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol. (2003) (105)
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition (2016) (105)
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. (1999) (105)
Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. (1984) (103)
Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. (1993) (103)
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. (2013) (102)
Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. (2003) (101)
Disruption of αβ but not of γδ T cell development by overexpression of the helix–loop–helix protein Id3 in committed T cell progenitors (1999) (99)
New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. (2007) (99)
Location of genes involved in invasion and metastasis on human chromosome 7. (1987) (95)
BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. (2005) (94)
Human T cell gamma chain joining regions and T cell development. (1987) (93)
The nature of circulating CD27+CD43+ B cells (2011) (92)
EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine (2012) (91)
Genetic aberrations in paediatric acute leukaemias and implications for management of patients. (2010) (90)
Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. (1985) (90)
Age-related changes in the cellular composition of the thymus in children. (2005) (89)
Generation of flow cytometry data files with a potentially infinite number of dimensions (2008) (88)
Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. (1996) (88)
Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. (1995) (85)
Genetic variation in ICF syndrome: Evidence for genetic heterogeneity (2000) (84)
The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. (2002) (83)
Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. (2008) (83)
Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. (1990) (82)
Development of human T lymphocytes and their thymus-dependency. (1990) (80)
The Nuclear Effector of Wnt-Signaling, Tcf1, Functions as a T-Cell–Specific Tumor Suppressor for Development of Lymphomas (2012) (79)
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia (2003) (76)
Circulating Human CD27−IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs (2015) (76)
Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. (1994) (76)
Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. (2001) (76)
Pitfalls in TCR gene clonality testing: teaching cases (2008) (75)
Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia. (1991) (74)
Human IgE(+) B cells are derived from T cell-dependent and T cell-independent pathways. (2014) (74)
Characterization of ABF-1, a Novel Basic Helix-Loop-Helix Transcription Factor Expressed in Activated B Lymphocytes (1998) (74)
Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. (1993) (73)
Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency (2007) (71)
MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. (2009) (70)
Intensified therapy for infants with acute lymphoblastic leukemia (1998) (70)
Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. (2001) (69)
Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. (2014) (69)
Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. (2002) (68)
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. (2011) (68)
Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. (1988) (68)
Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. (2017) (67)
Detection of minimal residual disease in acute leukemia patients. (1996) (66)
CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping (2018) (66)
Cryptosporidium Infection in Patients With Primary Immunodeficiencies (2007) (65)
PID Comes Full Circle: Applications of V(D)J Recombination Excision Circles in Research, Diagnostics and Newborn Screening of Primary Immunodeficiency Disorders (2011) (64)
Flow-cytometric immunophenotyping of normal and malignant lymphocytes (2006) (64)
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. (1999) (63)
Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia (2014) (62)
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC) (2018) (62)
N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. (2000) (62)
Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. (2004) (60)
Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and of one case with a variant translocation. (1987) (60)
Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression (2006) (60)
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. (2018) (60)
High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype. (1993) (59)
Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum (2013) (59)
Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. (1991) (58)
Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL. (2007) (58)
Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes (2014) (57)
Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. (1991) (57)
MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR. (2013) (57)
Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. (1998) (56)
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS (2019) (56)
The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System (2019) (56)
Classification systems for acute and chronic leukaemias. (2003) (55)
Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma. (2013) (55)
Immunophenotypical detection of minimal residual disease in acute leukemia. (1999) (55)
Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. (2009) (55)
Role of Artemis in DSB repair and guarding chromosomal stability following exposure to ionizing radiation at different stages of cell cycle. (2007) (53)
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. (1989) (53)
IgE‐expressing memory B cells and plasmablasts are increased in blood of children with asthma, food allergy, and atopic dermatitis (2018) (53)
Effects of Delta1 and Jagged1 on Early Human Hematopoiesis: Correlation with Expression of Notch Signaling‐Related Genes in CD34+ Cells (2006) (52)
TACI mutations and disease susceptibility in patients with common variable immunodeficiency (2009) (52)
tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. (1993) (51)
Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. (1988) (51)
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases (2016) (50)
Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. (1997) (50)
Defective B-cell memory in patients with Down syndrome. (2014) (50)
Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency. (2016) (48)
Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles. (2002) (48)
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy. (2019) (48)
Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies. (2019) (47)
Reviewing Omenn syndrome (2001) (47)
High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. (1992) (47)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment (2018) (47)
Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination (2008) (46)
Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature. (1991) (46)
Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias. (1999) (46)
DNA-PKcs deficiency in human: long predicted, finally found (2009) (46)
Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies. (1999) (46)
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia (2017) (45)
Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease. (1989) (44)
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges (2017) (44)
The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice. (1987) (44)
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. (2004) (42)
Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling. (2010) (42)
Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age (2017) (42)
The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. (2006) (41)
Two types of gamma T cell receptors expressed by T cell acute lymphoblastic leukemias (1987) (40)
Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients. (2010) (40)
The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. (1995) (40)
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective (2020) (40)
Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection (2005) (38)
Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers. (1993) (38)
Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. (1993) (37)
TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells. (2006) (37)
Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells (2017) (37)
Introduction to the diagnosis and classification of monocytic‐lineage leukemias by flow cytometry (2017) (36)
Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood (2014) (36)
Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. (1999) (35)
Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletion (2011) (35)
Triple immunological staining with colloidal gold, fluorescein and rhodamine as labels. (1985) (35)
Immunoglobulin/T-cell receptor clonality diagnostics. (2007) (35)
Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease. (1990) (35)
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. (2016) (34)
Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. (2017) (34)
IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells. (2011) (34)
Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study. (2016) (34)
B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma. (2014) (34)
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. (2006) (34)
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. (1993) (34)
Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia (2013) (33)
Flow cytometric immunobead assay for fast and easy detection of PML–RARA fusion proteins for the diagnosis of acute promyelocytic leukemia (2012) (33)
Unique selection determinant in polyclonal V delta 2-J delta 1 junctional regions of human peripheral gamma delta T lymphocytes. (1994) (33)
Effects of nongenetic factors on immune cell dynamics in early childhood: The Generation R Study (2017) (33)
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. (2018) (32)
Unraveling the Consecutive Recombination Events in the Human IGK Locus1 (2004) (32)
In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells (2018) (32)
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach (2008) (32)
XLA Patients with BTK Splice-Site Mutations Produce Low Levels of Wild-Type BTK Transcripts (2002) (31)
EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System (2019) (31)
Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube (2020) (31)
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19 (2021) (31)
Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. (1988) (30)
Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma. (1999) (30)
CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities. (2015) (30)
Checkpoints of B cell differentiation: visualizing Ig‐centric processes (2011) (30)
Thyrotropin acts as a T-cell developmental factor in mice and humans. (2014) (30)
Two Patients with Complete Defects in Interferon Gamma Receptor-Dependent Signaling (2007) (30)
Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. (2000) (30)
Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma. (1989) (29)
Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. (1998) (29)
Rearrangement and expression of T-cell receptor delta genes in T-cell acute lymphoblastic leukemias. (1989) (29)
Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. (2001) (28)
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients. (2014) (28)
Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation. (2011) (28)
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. (1989) (28)
Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme. (1997) (28)
Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. (1992) (28)
EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets. (2019) (27)
Unravelling human T-cell receptor junctional region sequences. (1994) (27)
The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation (2012) (27)
Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. (2016) (27)
Analysing the developing lymphocyte system of neonates and infants (1999) (27)
Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis. (1993) (27)
The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations. (2007) (26)
Distribution of subsets of blood monocytic cells throughout life. (2019) (26)
Frequent issues and lessons learned from EuroFlow QA. (2018) (26)
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. (2019) (26)
Detailed immunophenotyping of B‐cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection (2017) (26)
The TEL‐AML1 real‐time quantitative polymerase chain reaction (PCR) might replace the antigen receptor‐based genomic PCR in clinical minimal residual disease studies  in children with acute lymphoblastic leukaemia (2002) (25)
TdT positive B‐cell acute lymphoblastic leukaemia (B‐ALL) without Burkitt characteristics (1988) (25)
Immunophenotypic dissection of normal hematopoiesis. (2019) (25)
Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens. (1986) (25)
Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID (2020) (24)
From big flow cytometry datasets to smart diagnostic strategies: The EuroFlow approach. (2019) (24)
The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders (2001) (24)
Detection of residual disease in acute leukemia using immunological markers. (1988) (24)
How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers. (2017) (23)
Lot-to-lot stability of antibody reagents for flow cytometry. (2017) (23)
Clonality analysis for antigen receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936. (2003) (22)
Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma. (1989) (22)
Fetal Growth Influences Lymphocyte Subset Counts at Birth: The Generation R Study (2008) (22)
B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells. (2006) (21)
Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging (2018) (20)
Localization of human myeloid-associated surface antigen detected by a panel of 20 monoclonal antibodies to the q12-qter region of chromosome 11. (1984) (20)
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia. (2009) (20)
Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia. (2004) (20)
Harmonization of light scatter and fluorescence flow cytometry profiles obtained after staining peripheral blood leucocytes for cell surface‐only versus intracellular antigens with the Fix & Perm™ reagent (2009) (19)
Neonatal Blood Lymphocyte Subpopulations: A Different Perspective When Using Absolute Counts (2000) (19)
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19 (2021) (19)
A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression (2015) (19)
Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia (2001) (19)
Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality (2015) (19)
Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells. (2017) (18)
Successful RAG1-SCID gene therapy depends on the level of RAG1 expression. (2014) (17)
Bilateral exudative pleuritis, an unusual pulmonary onset of mixed connective tissue disease. (1985) (17)
Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias. (1991) (17)
Lack of common TCRA and TCRB clonotypes in CD8+/TCRαβ+ T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8+ T-LGL (2014) (17)
Polyclonal expansion of T-cell receptor-gamma delta+ T lymphocytes associated with neutropenia and thrombocytopenia. (1992) (17)
Strategies for B-Cell Receptor Repertoire Analysis in Primary Immunodeficiencies: From Severe Combined Immunodeficiency to Common Variable Immunodeficiency (2015) (16)
EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children (2020) (16)
The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age (2019) (16)
T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene. (1991) (16)
Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia. (1999) (16)
Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease. (2006) (16)
Southern blot detection of immunoglobulin lambda light chain gene rearrangements for clonality studies. (1995) (16)
Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children. (1993) (16)
Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects. (1990) (16)
The Cellular Immune Response to Rabies Vaccination: A Systematic Review (2019) (16)
Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones (2017) (15)
Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia (2018) (15)
Decreased IL7Rα and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin (2016) (15)
De novo deletion (2) (p11.2p13): clinical, cytogenetic, and immunological data. (1994) (15)
Phenotypic and genotypic characteristics of human early T-cell differentiation: the T-cell acute lymphoblastic leukaemia model. (1994) (15)
Quantification of T-Cell and B-Cell Replication History in Aging, Immunodeficiency, and Newborn Screening (2019) (15)
Non-random expression of T cell receptor gamma and delta variable gene segments in functional T lymphocyte clones from human peripheral blood. (1989) (15)
The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories (2021) (15)
Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency (2020) (14)
Combined TCRG and TCRA TREC analysis reveals increased peripheral T-lymphocyte but constant intra-thymic proliferative history upon ageing. (2013) (14)
Homeostatic and Maturation-associated Proliferation in the Peripheral B-Cell Compartment (2007) (14)
The Human Thymus Is Enriched for Autoreactive B Cells (2016) (14)
Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells (2016) (14)
Flow cytometric immunophenotyping in the diagnosis and follow-up of immunodeficient children (2001) (14)
Identification of immunoglobulin lambda isotype gene rearrangements by Southern blot analysis. (1996) (14)
Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma (2019) (13)
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR. (2019) (13)
Basal Ca2+ signaling is particularly increased in mutated chronic lymphocytic leukemia (2014) (13)
BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency (2019) (12)
Immunological marker analysis of mitogen-induced proliferating lymphocytes using BrdU incorporation or screening of metaphases. Staphylococcal protein A is a potent mitogen for CD4+ lymphocytes. (1990) (12)
Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools (2021) (12)
Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence (2016) (12)
Small-cell undifferentiated (neuroendocrine) carcinoma of the cecum in a child with common variable immunodeficiency. (1993) (12)
Correction for erythroid cell contamination in microassay for immunophenotyping of neonatal lymphocytes (1999) (12)
Population matched (PM) germline allelic variants of immunoglobulin (IG) loci: New pmIG database to better understand IG repertoire and selection processes in disease and vaccination (2020) (11)
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome. (2021) (11)
Dissection of B-cell development to unravel defects in patients with a primary antibody deficiency. (2011) (11)
Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma. (2000) (11)
Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukaemia. (1991) (11)
Recombination in the human IGK locus. (2006) (11)
Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients (2020) (10)
An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia. (2004) (10)
Bronchoalveolar lavage in extrapulmonary sarcoidosis. (1988) (10)
Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model (2019) (10)
Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells. (1994) (10)
The 78C --> T (T254M) XHIM mutation: lack of a tight phenotype-genotype relationship. (1999) (10)
Acute lymphoblastic leukemia followed by a clonally‐unrelated EBV‐positive non‐Hodgkin lymphoma and a clonally‐related myelomonocytic leukemia cutis (2004) (10)
Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage. (2018) (10)
Detection of minimal residual disease in acute leukemia. (2004) (10)
Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia. (1993) (10)
Unraveling of the Polymorphic Cλ2-Cλ3 Amplification and the Ke+Oz− Polymorphism in the Human Igλ Locus (2002) (10)
Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci (2015) (10)
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS (2014) (10)
Deficiencies in the CD19 complex. (2018) (10)
Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations (2021) (9)
SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance (2001) (9)
Complete Multilineage CD4 Expression Defect Associated With Warts Due to an Inherited Homozygous CD4 Gene Mutation (2019) (9)
Single-cell immune profiling reveals novel thymus-seeding populations, T cell commitment, and multi-lineage development in the human thymus (2022) (9)
Proteomics for Low Cell Numbers: How to Optimize the Sample Preparation Workflow for Mass Spectrometry Analysis (2021) (9)
The scid mouse environment causes immunophenotypic changes in human immature T‐cell lines (1994) (9)
PJA-BP expression and TCR delta deletion during human T cell differentiation. (1998) (9)
Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia (2017) (9)
T-cell receptor V delta-J alpha rearrangements in human thymocytes: the role of V delta-J alpha rearrangements in T-cell receptor-delta gene deletion. (1998) (8)
BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia. (2008) (8)
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study (2020) (8)
Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination (2021) (8)
Lymphoma with multi-gene rearrangement on the level of immunoglobulin heavy chain, light chain, and T-cell receptor beta chain. (1998) (8)
Understanding the reconstitution of the B‐cell compartment in bone marrow and blood after treatment for B‐cell precursor acute lymphoblastic leukaemia (2017) (8)
A combined immunodeficiency with oligoclonal CD8+, V beta 3-expressing, cytotoxic T lymphocytes in the peripheral blood. (1992) (7)
Split-signal FISH for detection of chromosome aberrations (2005) (7)
Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis. (1993) (7)
Persistent subclinical immune defects in HIV-1-infected children treated with antiretroviral therapy (2015) (7)
A DNA binding protein in human thymocytes recognizes the T cell receptor-delta-deleting element psi J alpha. (1996) (7)
Low frequency of reverse transcription polymerase chain reaction‐detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease (2001) (6)
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study (2021) (6)
B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review (2021) (6)
Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation (2021) (6)
Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival (2020) (6)
Molecular diagnostics of primary immunodeficiencies: benefits and future challenges. (2009) (6)
Improved Standardization of Flow Cytometry Diagnostic Screening of Primary Immunodeficiency by Software-Based Automated Gating (2020) (6)
Simultaneous occurrence of acute monoblastic leukemia and an abnormal B-cell clone with both cell types characterized by specific cytogenetic and immunological markers. (2009) (6)
High-Sensitive TRBC1-Based Flow Cytometric Assessment of T-Cell Clonality in Tαβ-Large Granular Lymphocytic Leukemia (2022) (6)
Alternative splicing restricts translation of rearrangements at the T-cell receptor delta/alpha locus. (1995) (5)
Variation in the IGF‐1 gene is associated with lymphocyte subset counts in neonates: The Generation R Study (2009) (5)
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study (2021) (5)
Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination (2022) (5)
BMA031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states. (1990) (5)
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma (2021) (5)
Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study (2022) (5)
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients (2021) (4)
Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. (1990) (4)
Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-κB pathway (2019) (4)
Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia (2021) (4)
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance (2022) (4)
Pulmonary mycobacterium avium intracellulare infection in an immunocompetent child. (2004) (4)
Receptor diversity of human T-cell receptor gamma delta expressing cells. (1992) (4)
Longitudinal follow-up of blood lymphocyte subpopulations from birth to 1 year of age. (1998) (4)
Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia (2020) (4)
Proposals for immunological classification of acute leukemias. (1995) (3)
A novel radiosensitive SCID patient with a pronounced G(2)/M sensitivity. (2010) (3)
The small subpopulation of T cell marker+/TdT+ cells in the human bone marrow may represent prothymocytes. (1985) (3)
EuroFlow and its activities: Introduction to the special EuroFlow issue of The Journal of Immunological Methods. (2019) (3)
Trimetrexate efficacy and pharmacokinetics during treatment of refractory Pneumocystis carinii pneumonia in an infant with severe combined immunodeficiency disease (1990) (3)
Identification of a new cluster of T‐cell receptor delta recombining elements (2003) (3)
Lymphoma with multi‐gene rearrangement on the level of immunoglobulin heavy chain, light chain, and T‐cell receptor β chain (1998) (2)
Repertoire selection of human gamma delta T cells. (1990) (2)
Cancer research in the European community--report from a meeting in Stockholm in 1995. (1996) (2)
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels (2022) (2)
Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting (2022) (2)
Reply to the Commentary on population matched (pm) germline allelic variants of immunoglobulin (IG) loci: relevance in infectious diseases and vaccination studies in human populations (2021) (2)
Correct interpretation of T‐ALL oncogene expression relies on normal human thymocyte subsets as reference material (2012) (2)
Expression of the human immunoglobulin heavy chain gene of the 14q+ chromosome in a t(8;14)-positive Burkitt lymphoma cell line demonstrated in somatic cell hybrids. (1986) (2)
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood (2022) (2)
Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients—A EuroFlow Study (2022) (1)
Regulation of CD19 surface expression in human B cells by CD81 (P3323) (2013) (1)
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping (2011) (1)
Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge (2023) (1)
Longitudinal Dynamics of Human B-Cell Response at the Single-Cell Level in Response to Tdap Vaccination (2021) (1)
[Immunoglobulin genes and T-cell receptor genes and the expression of immunological markers. II. Immunological diagnosis of malignant lymphatic diseases]. (1988) (1)
[Minimal residual disease in childhood acute lymphoblastic leukemia: diagnosis of the 21 century]. (2003) (1)
Real-time quantitative (RQ-)PCR approach to quantify the contribution of proliferation to B lymphocyte homeostasis. (2013) (1)
Alveolitis in an asymptomatic pigeon breeder. (1985) (1)
Tissue distribution and repertoire selection of human gamma delta T cells: comparison with the murine system. (1991) (1)
The potential use of basigin (CD147) as a prognostic marker in B‐cell precursor acute lymphoblastic leukaemia (2010) (1)
Longitudinal dynamics of human B-cell response at single-cell level in response to Tdap vaccination (2021) (1)
New frontiers of primary antibody deficiencies (2011) (1)
pmTR database: population matched (pm) germline allelic variants of T-cell receptor (TR) loci (2020) (0)
A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression (2015) (0)
BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency (2019) (0)
Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence (2016) (0)
Age-dependent normalisation functions for T-lymphocytes in healthy individuals (2021) (0)
Acute lymphoblastic leukemia. (2002) (0)
Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system (2023) (0)
Correction to: Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence (2018) (0)
Flow cytometric immunophenotyping of normal and malignant lymphocytes / Immunphänotypisierung normaler und maligner Lymphozyten mittels Durchflusszytometrie (2006) (0)
Redefining Non-Inferiority in Anamnestic Antibody Responses Using the Mean Increase of Log-Transformed Antibody Titers after Revaccination: Secondary Analysis of a Randomized Controlled Rabies Vaccination Trial (2020) (0)
Characterization of the early cellular immune response induced by HPV vaccines (2022) (0)
EXTH-54. CO-CULTURE OF PATIENT-DERIVED GLIOBLASTOMA CELL LINES WITH AUTOLOGOUS PBMCS FOR THE INVESTIGATION OF ONCOLYTIC VIRUS RESPONSE (2022) (0)
MO246: Belimumab Disrupts Memory B Cell Trafficking in Patients with Systemic Lupus Erythematosus (2022) (0)
The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age (2019) (0)
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (2020) (0)
[Terminal deoxynucleotidyltransferase (TdT)-positive cells in cerebrospinal fluid of children with leukemia or non-Hodgkin lymphoma: implications for the diagnosis of central nervous system leukemia]. (1986) (0)
Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia (2023) (0)
Reply to the Commentary on population matched (pm) germline allelic variants of immunoglobulin (IG) loci: relevance in infectious diseases and vaccination studies in human populations (2021) (0)
The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital (2022) (0)
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome (2022) (0)
pmTR database: population matched (pm) germline allelic variants of T-cell receptor (TR) loci (2022) (0)
Single cell guided deconvolution of bulk transcriptomics recapitulates differentiation stages of acute myeloid leukemia and predicts drug response (2023) (0)
[Pneumocystis carinii pneumonia in patients with a severe combined immunodeficiency]. (1991) (0)
Evaluation of B-Cell Kinetics After Acellular Pertussis Vaccination in Four Cohorts of Different Age and Priming Background (2021) (0)
Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells. (1988) (0)
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome (2021) (0)
Corrigendum to "Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage" [Clin Immunol 2018; 197: 224-230]. (2020) (0)
Studying the replication history of human B lymphocytes by real-time quantitative (RQ)-PCR. (2013) (0)
Corrigendum: Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective (2021) (0)
Erratum to "New Insights and Unresolved Issues Regarding Insertional Mutagenesis in X-linked SCID Gene Therapy". (2008) (0)
[Detection of low numbers of malignant cells in patients with leukemia or non-Hodgkin lymphoma: use of immunological markers]. (1986) (0)
Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacques J. M. J. M. Van Dongen?

Jacques J. M. J. M. Van Dongen is affiliated with the following schools:

Leiden University